ZHANG Yi, LU Ping. Clinical study of Xianchan Tablets combined with chemotherapy in the treatment of elderly patients with esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 75-77. DOI: 10.7619/jcmp.202003021
Citation: ZHANG Yi, LU Ping. Clinical study of Xianchan Tablets combined with chemotherapy in the treatment of elderly patients with esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(3): 75-77. DOI: 10.7619/jcmp.202003021

Clinical study of Xianchan Tablets combined with chemotherapy in the treatment of elderly patients with esophageal cancer

More Information
  • Received Date: November 07, 2019
  • Objective To analyze the effect of Xianchan Tablets combined with chemotherapy in treatment of elderly patients with esophageal cancer. Methods Sixty-eight elderly patients with esophageal cancer treated in the hospital were selected by digital random grouping, including 34 cases in the control group and 34 cases in the observation group. The control group was treated with general chemotherapy regimen, while the observation group was given Xianchan Tablets combined with chemotherapy. The treatment effects of the two groups were observed and compared. Results The treatment response rate was higher in the observation group than that in the control group, and the difference was statistically significant(91.2% vs. 70.6%, P < 0.05). After treatment, the immunoglobulin A(IgA), CD3+, neuron specific enolase(NSE), carcinoembryonic antigen(CEA)indexes of two groups showed significant differences(P < 0.05). Follow-up within 3 months after treatment showed that there was a significant difference in the quality of life score between the observation group and the control group(P < 0.05). The incidence of adverse reactions after treatment was 14.7% in the observation group and 11.8% in the control group, but no significant difference between the two groups was observed(P > 0.05). Conclusion Chemotherapy combined with Xianchan Tablets has significant efficacy in the clinical treatment of elderly patients with esophageal cancer, which can improve serum tumor markers and immune function indicators, without adverse reactions increasing.
  • 郭书伟. 中药八珍汤配合放化疗对中晚期食管癌患者免疫功能及生活质量的影响研究[J]. 亚太传统医药, 2017, 13(10): 126-127.
    徐大兴, 李平. 中晚期食管癌的中西医结合治疗研究进展[J]. 江西中医药, 2017, 48(1): 78-80.
    吴成亚, 冯颖, 李杰. 基于循证医学的中医药治疗食管癌作用特点研究概述[J]. 山东中医杂志, 2016, 35(12): 1092-1095.
    韩自力, 孙建锋. 食管癌术后患者应用中药干预对生活质量及生存时间的影响研究[J]. 海军医学杂志, 2016, 37(5): 428-431

    , 438.
    王影利. 健脾消瘀中药联合同步放化疗治疗中晚期食管癌43例疗效观察[J]. 国医论坛, 2016, 31(5): 48-50.
    娄丽丽, 谢吻, 张盼, 等. 中药注射剂联合化疗治疗食管癌有效性的网状Meta分析[J]. 兰州大学学报: 医学版, 2016, 42(1): 55-60.
    田金徽, 赵晔, 李金龙, 等. 10种中药注射剂联合长春瑞滨+顺铂化疗方案治疗非小细胞肺癌的网状Meta分析[J]. 中国药物评价, 2015, 32(1): 45-49.
    胡翔燕, 关徐涛, 高萍. 益气养阴中药配合替吉奥胶囊治疗中晚期食管癌20例[J]. 山东中医药大学学报, 2015, 39(5): 431-433.
    陈高阳, 陈珏. 健脾消瘀中药联合同步放化疗治疗中晚期食管癌25例临床研究[J]. 江苏中医药, 2015, 47(9): 39-40.
    姚庆华, 王赟, 谷建钟, 等. 肠内免疫营养对食管癌化疗患者脾虚证候及免疫功能影响的临床研究[J]. 中华中医药杂志, 2014, 29(7): 2321-2325.
    姚庆华, 王赞, 谷建钟, 等. 肠内免疫营养及中药对食管癌化疗患者脾虚证候的影响[J]. 浙江中医杂志, 2013, 48(10): 715-718.
    陈颢. 食管癌术后化疗配合中药调理临床观察[J]. 中华中医药学刊, 2014, 32(6): 1527-1531.
    宋希荣. 中药对中晚期食管癌化疗毒副反应的影响[J]. 中国医学创新, 2013, 10(17): 50-51.
    付金书. 参术扶正方联合放化疗治疗中晚期食管癌40例[J]. 中国中医药现代远程教育, 2008, 6(10): 1212-1212.
    刘志朝. 中药配合化疗治疗中晚期食管癌患者78例疗效分析[J]. 中医药导报, 2013, 19(5): 60-61.
  • Related Articles

    [1]SONG Huahua, ZHU Ronghua, SHI Li. Correlations of serum levels of brain-derived neurotrophic factor, malondialdehyde, endothelin-1 and heat shock protein 70 with cognitive dysfunction in patients with obstructive sleep apnea hypopnea syndrome[J]. Journal of Clinical Medicine in Practice, 2025, 29(3): 70-74. DOI: 10.7619/jcmp.20242760
    [2]SUN Qin, ZHANG Wen, XU Mengyuan, XU Suqing, ZHAO Haihe, JIN Minli. Effect of four traditional Chinese drugs for reinforcing kidney combined with Tongqiao Huoxue Decoction on serum neurotransmitters and neurological function in patients with post-stroke cognitive impairment[J]. Journal of Clinical Medicine in Practice, 2025, 29(1): 89-93. DOI: 10.7619/jcmp.20242642
    [3]SUN Yan, WANG Xia, HE Fengying, NIU Meiyan, YU Ruiping, ZHANG Airong. Effects of dietary behavior intervention on expressions of serum α-synuclein, brain-derived neurotrophic factor and glutamate in children with autism spectrum disorders[J]. Journal of Clinical Medicine in Practice, 2022, 26(23): 80-84. DOI: 10.7619/jcmp.20221894
    [4]ZHONG Yunian, ZHAO Yilin, XIAO Wenhuan, YANG Xiang, XU Ying. Relationships of cognitive function with inflammatory factors and glial cell line-derived neurotrophic factor in patients with bipolar disorders[J]. Journal of Clinical Medicine in Practice, 2022, 26(6): 58-62. DOI: 10.7619/jcmp.20213016
    [5]WANG Jing, ZHAO Yilin, XIAO Wenhuan, WU Hui. Comparison in hematological inflammatory markers and brain-derived neurotrophic factor in patients with schizophrenia and those with bipolar disorder[J]. Journal of Clinical Medicine in Practice, 2021, 25(22): 74-77. DOI: 10.7619/jcmp.20212571
    [6]TAN Sanyang, HUANG Hai, LIN Zhangping. Predictive value of umbilical vein blood brain-derived neurotrophic factor level for brain injury of neonates delivered by the pregnant with gestational diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2021, 25(6): 89-92. DOI: 10.7619/jcmp.20201406
    [7]PAN Xinming, HU Xuefeng, WEN Lu, HU Xiuxiu, ZHANG Xiaobin. Effect of atypical antipsychotics on glial cell line-derived neurotrophic factor levels in schizophrenia patients[J]. Journal of Clinical Medicine in Practice, 2017, (21): 12-14,18. DOI: 10.7619/jcmp.201721003
    [8]DING Zhaosheng, ZHOU Fang, LIN Maming, WANG Yun. Influence and clinical effect of fluoxetine on the level of serum brain-derived neurotrophic factor in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2012, (24): 17-19.
    [9]LIU Jin-wen, ZHANG Xiao-bin, ZHOU Hong-hui, ZHANG Yu-mei. Study of the serum levels of brain- derived neurotrophic factor and glial cell line- derived neurotrophic factor in patients with recurrent depression[J]. Journal of Clinical Medicine in Practice, 2012, (9): 29-31. DOI: 10.3969/j.issn.1672-2353.2012.09.010
    [10]CAI Yi-yun, SHI Shen-xun, XU San-rong, SUN Da-yu. THE IMPACT OF CHRONIC STRESS ON MONOAMINE NEUROTRANSMITTERS IN CSF OF RATS[J]. Journal of Clinical Medicine in Practice, 2005, (1): 2-4. DOI: 10.3969/j.issn.1672-2353.2005.01.002
  • Cited by

    Periodical cited type(6)

    1. 孟凯. 电视胸腔镜辅助环抱器治疗胸部外伤合并肋骨骨折患者的临床效果观察. 大医生. 2025(04): 23-25 .
    2. 王晓康. 肋骨接骨板置入内固定术对肋骨骨折安全性及疼痛的影响. 中国医药指南. 2024(04): 14-16 .
    3. 成刚,王长兴. 基于胸腔镜的复位内固定术治疗老年肋骨骨折患者的临床疗效研究. 实用临床医药杂志. 2024(05): 89-93 . 本站查看
    4. 彭亮,郭剑,查波辉,吴珊燕,舒华宝,吴胜华,杨子熠,王小娟. 急诊创伤性血气胸在床边超声引导下精准化穿刺置管引流术的治疗效果. 检验医学与临床. 2024(09): 1245-1249 .
    5. 冉隆强,李勇,贾萌. 胸腔镜辅助内固定术对多发肋骨骨折合并胸部创伤患者肺功能及预后的影响. 中国医刊. 2023(05): 517-520 .
    6. 周攀,吴中权,朱杰,舒圣,程玲玲. 胸腔镜微创手术和快速康复治疗严重胸部碾轧伤1例. 中国医药. 2023(08): 1255-1258 .

    Other cited types(0)

Catalog

    Article views (328) PDF downloads (11) Cited by(6)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return